The patent EP4562219A1 was granted to Schott Pharma on Jun 4, 2025 following the initial filing on Jul 26, 2023 under the application number EP23748501A . The current legal status of the patent is Request For Examination Was Made.
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents